[go: up one dir, main page]

HRP20070094T3 - NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI - Google Patents

NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Info

Publication number
HRP20070094T3
HRP20070094T3 HR20070094T HRP20070094T HRP20070094T3 HR P20070094 T3 HRP20070094 T3 HR P20070094T3 HR 20070094 T HR20070094 T HR 20070094T HR P20070094 T HRP20070094 T HR P20070094T HR P20070094 T3 HRP20070094 T3 HR P20070094T3
Authority
HR
Croatia
Prior art keywords
optionally substituted
hydrogen
6alkyl
groups
hydroxy
Prior art date
Application number
HR20070094T
Other languages
English (en)
Croatian (hr)
Inventor
Alihodzic Sulejman
Michael Berge John
Lewis Jarvest Richard
Original Assignee
Glaxo Group Limited
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Limited, Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxo Group Limited
Publication of HRP20070094T3 publication Critical patent/HRP20070094T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20070094T 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI HRP20070094T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds
PCT/EP2004/005083 WO2004101587A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 memberred-ring compounds

Publications (1)

Publication Number Publication Date
HRP20070094T3 true HRP20070094T3 (hr) 2008-05-31

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070094T HRP20070094T3 (hr) 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Country Status (15)

Country Link
US (1) US20070293472A1 (xx)
EP (1) EP1628989B1 (xx)
JP (1) JP2006528667A (xx)
AR (1) AR044304A1 (xx)
AT (1) ATE348837T1 (xx)
CA (1) CA2525455A1 (xx)
CL (1) CL2004001012A1 (xx)
DE (1) DE602004003809T2 (xx)
DK (1) DK1628989T3 (xx)
ES (1) ES2278319T3 (xx)
HR (1) HRP20070094T3 (xx)
PL (1) PL1628989T3 (xx)
PT (1) PT1628989E (xx)
SI (1) SI1628989T1 (xx)
WO (1) WO2004101587A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
MXPA06012923A (es) * 2004-05-06 2007-07-18 Glaxosmithkline Zagreb Macrolidos asociados a ester utiles para el tratamiento de infecciones microbianas.
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
JP2009514918A (ja) * 2005-11-09 2009-04-09 グラクソ グループ リミテッド 新規４’’−置換エリスロマイシン誘導体
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
US9072759B2 (en) 2008-10-24 2015-07-07 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CA2799937A1 (en) * 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
JP6208742B2 (ja) 2012-03-27 2017-10-04 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗生物質を投与するための非経口製剤
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
CA2049359A1 (en) * 1989-03-28 1990-09-29 Leslie A. Freiberg Erythromycin derivatives
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
WO1997042205A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
PL1628989T3 (pl) 2007-05-31
EP1628989A1 (en) 2006-03-01
JP2006528667A (ja) 2006-12-21
SI1628989T1 (sl) 2007-06-30
US20070293472A1 (en) 2007-12-20
ATE348837T1 (de) 2007-01-15
PT1628989E (pt) 2007-03-30
WO2004101587A1 (en) 2004-11-25
EP1628989B1 (en) 2006-12-20
ES2278319T3 (es) 2007-08-01
AR044304A1 (es) 2005-09-07
DK1628989T3 (da) 2007-10-08
DE602004003809D1 (de) 2007-02-01
DE602004003809T2 (de) 2007-10-11
CA2525455A1 (en) 2004-11-25
CL2004001012A1 (es) 2005-03-18

Similar Documents

Publication Publication Date Title
HRP20070094T3 (hr) NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI
RS52397B (en) PYRIDO / 2,1-A / ISOCHINOLINE DERIVATIVES AS DPP-IV INHIBITORS
CO5631447A2 (es) Derivados de heteriarilamida benzocondesada de tieno- piridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos, y metodos pra su uso
YU48088B (sh) Derivati indola
HUP0301671A2 (hu) 4-Fenil-piridin-származékok, mint neurokinin-1-receptor antagonisták, eljárás az előállításukra és alkalmazásuk
DE60017115D1 (de) Amid-derivate und deren medizinische verwendung
CO5290258A1 (es) Derivados de fenilheteroalquilaminas, proceso para su prepracion y composiciones farmaceuticas que contienen dichos derivados
FI934825A0 (fi) 5-arylindol derivat
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
PE20030062A1 (es) Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
BR9103433A (pt) Derivados de 4-benzil-isoxazol
HRP20080236T3 (en) Quinoline derivatives as phosphodiesterase inhibitors
HRP20070307T3 (hr) Derivati n-[fenil(pirolidin-2-il)metil]benzamida i n-[(azepan-2-il)fenilmetil]benzamida, postupak njihovog dobivanja i njihova upotreba u terapiji
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
PE20001289A1 (es) Nuevos antibioticos macrolidos
AR035254A1 (es) Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica
YU6799A (sh) Derivati tetrahidrohinolina kao antagonisti eaa
AR053311A1 (es) Macrolonas - quinolonas amino sustituidas
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
AR049269A1 (es) Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas.
CO5611121A2 (es) Derivados de fenil amidas con silicio utiles como microbicidas
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
AR041860A1 (es) Compuesto macrolido de oxima sustituido en la posicion 4'', procedimiento de preparacion del mismo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende